Paid Clinical Trials Memphis
Discover 327 paid clinical trials in Memphis, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use DisorderA Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use Disorder
Sponsor:
Eli Lilly and Company
Location:
Code:
NCT06817356
Conditions
Alcohol Use Disorder
Eligibility Criteria
Sex: All
Age: 21 - 65
Healthy Volunteers: Not accepted
Interventions
Mazdutide
Placebo
Observational StudyDetermination of the Sensitivity and Specificity of a Smartphone Application to Detect Retinoblastoma
Sponsor:
St. Jude Children's Research Hospital
Location:
Code:
NCT03016156
Conditions
Retinoblastoma
Cataracts Infantile
Glaucoma, Congenital
Leucocoria
Eligibility Criteria
Sex: All
Age: 0 - 7
Healthy Volunteers: Not accepted
Interventions
CRADLE
Red reflex testing
Observational StudyAssessment of Biomarkers in Patients With Decompensated Heart Failure and Underlying Coronary Artery Disease
Sponsor:
CirQuest Labs, LLC
Location:
Code:
NCT03551756
Conditions
Heart Failure With Reduced Ejection Fraction
Coronary Artery Disease
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Biomarker Assessment
MPH HCl EREfficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years with ADHD
Sponsor:
Ironshore Pharmaceuticals and Development, Inc
Location:
Code:
NCT06431256
Conditions
Attention Deficit Hyperactivity Disorder
Eligibility Criteria
Sex: All
Age: 4 - 5
Healthy Volunteers: Not accepted
Interventions
HLD200 methylphenidate hydrochloride capsules
Placebo HLD200 capsules
Operative vs. Non-OperativeMulti-Center Adolescent Clavicle Fracture Trial: Operative Vs. Non-Operative Treatment
Sponsor:
Boston Children's Hospital
Location:
Code:
NCT04250415
Conditions
Clavicle Fracture
Eligibility Criteria
Sex: All
Age: 10 - 18
Healthy Volunteers: Not accepted
Interventions
Surgery
Vaping CessationImplementing an Adolescent and Young Adult (AYA) mHealth Vaping Cessation Program Into Oncology Clinics
Sponsor:
St. Jude Children's Research Hospital
Location:
Code:
NCT05967585
Conditions
Vaping
Vaping Cessation
Eligibility Criteria
Sex: All
Age: 13 - 24
Healthy Volunteers: Not accepted
Interventions
Behavioral: Quitting Program (TIQ)
VITRAKVIStudy to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body
Sponsor:
Bayer
Location:
Code:
NCT04142437
Conditions
Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
larotrectinib(Vitrakvi, BAY2757556)
Prismocitrate 18Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT
Sponsor:
Vantive Health LLC
Location:
Code:
NCT05399537
Conditions
Regional Citrate Anticoagulation (RCA)
Continuous Renal Replacement Therapy (CRRT)
Acute Kidney Injury (AKI)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Prismocitrate 18
PrisMax System Version 3.x with calcium line accessory
Observational StudyStudy to Evaluate the Reliability, Validity and Safety of Subjective Mobile Refraction
Sponsor:
1800 Contacts, Inc.
Location:
Code:
NCT05049070
Conditions
Refractive Errors
Eligibility Criteria
Sex: All
Age: 18 - 39
Healthy Volunteers: Not accepted
Interventions
Mobile medical application to self administer a subjective refraction test
Standard of care refraction test
TesetaxelTesetaxel as First-line Therapy for Metastatic Breast Cancer
Sponsor:
Genta Incorporated
Location:
Code:
NCT01221870
Conditions
Breast Neoplasm
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Tesetaxel once every 3 weeks
Tesetaxel once weekly